BRNHF (Broncus Holding) Inventories, Raw Materials & Components: $1.59 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BRNHF Broncus Holding Corp BRNHF
40 GF Score
Price $0.08
! 7 Warning Signs
View Full Analysis

What is Broncus Holding Inventories, Raw Materials & Components?

Broncus Holding BRNHF 40 Inventories, Raw Materials & Components is $1.59 Mil as of Dec. 2025. GuruFocus rates BRNHF with a GF Score™ of 40/100. The stock has 7 warning signs investors should review.

Broncus Holding's inventories, raw materials & components for the quarter that ended in Dec. 2025 was $1.59 Mil.

Broncus Holding's quarterly raw materials declined from Dec. 2024 ($2.01 Mil) to Jun. 2025 ($0.00 Mil) but then increased from Jun. 2025 ($0.00 Mil) to Dec. 2025 ($1.59 Mil).

Broncus Holding's annual raw materials declined from Dec. 2023 ($2.10 Mil) to Dec. 2024 ($2.01 Mil) and declined from Dec. 2024 ($2.01 Mil) to Dec. 2025 ($1.59 Mil).

Broncus Holding Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Broncus Holding's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Broncus Holding Inventories, Raw Materials & Components Chart

Broncus Holding Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 2.24 1.94 2.10 2.01 1.59

Broncus Holding Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.10 0.00 2.01 0.00 1.59
BRNHF
40GF Score
Broncus Holding Corp BRNHF
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Broncus Holding Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $1.59 Mil mean?
Broncus Holding (BRNHF) has a Inventories, Raw Materials & Components of $1.59 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Broncus Holding and its competitors.
Is Broncus Holding's Inventories, Raw Materials & Components too high?
Broncus Holding's current Inventories, Raw Materials & Components is $1.59 Mil. Overall, Broncus Holding has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Broncus Holding's Inventories, Raw Materials & Components compare to ABT and SYK?
Broncus Holding's Inventories, Raw Materials & Components of $1.59 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Broncus Holding and its competitors. Broncus Holding's current Inventories, Raw Materials & Components is $1.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Broncus Holding stock overvalued right now?
Broncus Holding (BRNHF) has a current Inventories, Raw Materials & Components of $1.59 Mil. The current Inventories, Raw Materials & Components is $1.59 Mil. Broncus Holding's overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Broncus Holding (BRNHF), the current Inventories, Raw Materials & Components is $1.59 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Broncus Holding Business Description

Other Exchanges 02216:Hong Kong
Address No. 88 Jiangling Road, Xixing Street, Room 801, 8th Floor, Building 8, Binjiang District, Hangzhou, CHN
Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD. Geographically, the company operates in Chinese Mainland; European Union; and Other Regions.
40GF Score

Get the complete analysis for BRNHF

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price